2024-2030 China Dermatology Drug Industry Market Monitoring and Investment Prospect Research Report

Report Number: 1759299

Free catalog download: http://www.cninfo360.com/yjbg/yyhy/hxy/20240124/1759299.html

　　As an important part of the clinical treatment market, dermatology drugs have received widespread attention from the government and consumers, and the market is growing and developing.

　　According to the Chinese Health and Family Planning Commission, in 2018, the sales of dermatology drugs in China reached 1.74 billion yuan, a year-on-year increase of 9.9%. It is estimated that by 2022, the market size of dermatology drugs in China will reach 2.62 billion yuan.

　　According to the trend of market development, China's dermatology drug industry is divided into three main markets: prescription drug market, immunomodulator market, and Chinese patent medicine market.

　　The prescription drug market is dominated by new antibiotics, antifungal drugs and anti-inflammatory drugs, which are mainly dominated by large domestic and foreign pharmaceutical companies, and their Chinese-made drugs dominate the market.

　　The immunomodulator market is dominated by antibodies, steroids and hormone drugs, which are mainly dominated by large domestic pharmaceutical companies, with a relatively large market share.

　　The Chinese patent medicine market is dominated by epidermal proliferative drugs and anti-allergy drugs, which are mainly invested and operated by Chinese traditional Chinese medicine companies, and the market share also occupies a relatively large proportion.

　　According to the 2018 market data, the competitive landscape of China's dermatology drug industry is mainly concentrated in the prescription drug market and the immunomodulator market, and the competition is also fierce due to the relatively large share of these two markets, which are dominated by large enterprises in the pharmaceutical industry.

　　In the immunomodulator market, the competition is more intense, due to the intangible characteristics of immunomodulators, the main competitors in the market are mainly concentrated in large foreign pharmaceutical companies, while the pharmaceutical companies in the Chinese market are relatively backward.

　　In the Chinese patent medicine market, due to its low price, the market share is also large, but the competition is small, mainly dominated by domestic traditional Chinese medicine companies, while the competitiveness of foreign pharmaceutical companies is weak.

　　China's dermatology drug industry is growing and competitive, and there is still a lot of room for development in the market. Big pharma companies, as well as large foreign pharma companies, are looking for opportunities and seizing opportunities to meet the needs of Chinese consumers for dermatology drugs.

The "2024-2030 China Dermatology Drug Industry Market Monitoring and Investment Prospect Research Report" released by Boyan Consulting consists of seven chapters. Firstly, the market development environment of the dermatology drug industry and the overall operation situation of the dermatology drug industry are introduced, and then the current situation of the market operation of the dermatology drug industry is analyzed, and then the competition pattern of the dermatology drug market is introduced. Subsequently, the report analyzes the business status of key enterprises in dermatology drugs, and finally analyzes the development trend and investment forecast of the dermatology drug industry. If you want to have a systematic understanding of the dermatology drug industry or want to invest in the skin disease drug industry, this report is an indispensable and important tool for you.

The data of this research report mainly use national statistical data, General Administration of Customs, questionnaire survey data, and data collected by the Ministry of Commerce. Among them, the macroeconomic data mainly comes from the National Bureau of Statistics, some industry statistics mainly come from the National Bureau of Statistics and market research data, the enterprise data mainly comes from the National Bureau of Statistics large-scale enterprise statistical database and stock exchanges, etc., and the price data mainly comes from various market monitoring databases.

Table of contents of the text

Chapter 1 Overview of the development of the dermatology drug industry

Section 1 Knowledge of Dermatological Medications

1. Definition of dermatological drugs

2. Characteristics of dermatological drugs

Section 2 Classification of Dermatological Drugs in China

1. Corticosteroids

2. Antifungal drugs

3. Medication for the treatment of psoriasis

4. Antimicrobials

5. Anti-acne preparations

6. Antibiotics

Section 3 Analysis of Market Characteristics of Dermatological Drugs

Chapter 2 Analysis of the Market Development Status of China's Dermatology Drug Industry

Section 1 Development of China's dermatology drug industry

1. Analysis of the development status of the dermatology drug industry from 2019 to 2023

2. Development trends of China's dermatology drug industry from 2019 to 2023

3. Analysis of the operating performance of the dermatology drug industry from 2019 to 2023

4. 2019-2023 China's dermatology drug industry development hotspots

Section 2 Supply and demand of China's dermatology drug market

1. The supply capacity of China's dermatology drug industry from 2019 to 2023

2. Supply analysis of China's dermatology drug market from 2019 to 2023

3. Analysis of the market demand for dermatology drugs in China from 2019 to 2023

4. Price analysis of dermatological drug products in China from 2019 to 2023

Section 3 Market Analysis of Key Varieties of China's Skin Pharmaceutical Preparations Market

1. Terbinafine

2. Halomethasone

3. Calcipotriol

4. Mometasone furoate

5. Triamcinolone acetonide econazole

6. Mupiro Star

Chapter 3 2019-2023 China Dermatology Drug Industry Overall Operation Index Analysis

Section 1 Analysis of the overall scale of China's dermatology drug industry from 2019 to 2023

1. Analysis of the number and structure of enterprises from 2019 to 2023

2. Analysis of personnel size from 2019 to 2023

3. Analysis of industry asset scale from 2019 to 2023

4. Analysis of the industry market size from 2019 to 2023

Section 2 Analysis of the production and sales of dermatology drugs in China from 2019 to 2023

1. The total industrial output value of China's dermatology drug industry from 2019 to 2023

2. 2019-2023 sales revenue of China's dermatology drug industry

3. The production and sales rate of China's dermatology drug industry from 2019 to 2023

Section 3 Overall analysis of the financial indicators of China's dermatology drug industry from 2019 to 2023

1. Profitability analysis of the industry to which dermatology drugs belong from 2019 to 2023

2. Analysis of the solvency of the industry to which dermatology drugs belong from 2019 to 2023

3. Analysis of the operating capacity of the industry to which dermatology drugs belong from 2019 to 2023

4. Analysis of the development capacity of the dermatological drug industry from 2019 to 2023

Chapter 4 Regional Market Development Status and Forecast Analysis of China's Dermatology Drug Industry

Section 1 Market Development Status and Forecast Analysis in North China

1. The current situation and trend of economic development in North China

2. The market status of the dermatology drug industry in North China from 2019 to 2023

3. Market size analysis of the dermatology drug industry in North China from 2019 to 2023

4. Forecast of the market size of the dermatology drug industry in North China from 2024 to 2030

Section 2 Market Development Status and Forecast Analysis in Northeast China

1. The current situation and trend of economic development in Northeast China

2. The market status of the dermatology drug industry in Northeast China from 2019 to 2023

3. Market size analysis of the dermatology drug industry in Northeast China from 2019 to 2023

4. Forecast of the market size of the dermatology drug industry in Northeast China from 2024 to 2030

Section 3 Market Development Status and Forecast Analysis in East China

1. The current situation and trend of economic development in East China

2. The market status of the dermatology drug industry in East China from 2019 to 2023

3. Market size analysis of dermatology drug industry in East China from 2019 to 2023

4. Forecast of the market size of the dermatology drug industry in East China from 2024 to 2030

Section 4 Market Development Status and Forecast Analysis in Central China

1. The current situation and trend of economic development in Central China

2. The market status of the dermatology drug industry in Central China from 2019 to 2023

3. Market size analysis of dermatology drug industry in Central China from 2019 to 2023

4. Forecast of the market size of the dermatology drug industry in Central China from 2024 to 2030

Section 5 Market Development Status and Forecast Analysis in South China

1. The current situation and trend of economic development in South China

2. The market status of the dermatology drug industry in South China from 2019 to 2023

3. Market size analysis of dermatology drug industry in South China from 2019 to 2023

4. Forecast of the market size of the dermatology drug industry in South China from 2024 to 2030

Section 6 Market Development Status and Forecast Analysis in the Western Region

1. The current situation and trend of economic development in the western region

2. The market status of the dermatology drug industry in the western region from 2019 to 2023

3. Analysis of the market size of the dermatology drug industry in the western region from 2019 to 2023

4. Forecast of the market size of the dermatology drug industry in the western region from 2024 to 2030

Chapter 5 Analysis of the competitive landscape of China's dermatology drug industry from 2019 to 2023

Section 1 Analysis of the competitive structure of China's dermatology drug industry from 2019 to 2023

1. Competition among existing enterprises

2. Analysis of potential entrants

III. Substitute Substitute Weiwei Analysis

Fourth, the bargaining power of suppliers

Fifth, the bargaining power of customers

Section 2 Analysis of the concentration of China's dermatology drug industry from 2019 to 2023

1. Market concentration analysis

2. Analysis of enterprise concentration

3. Regional concentration analysis

Chapter 6 Analysis of the operation of some enterprises in dermatological drugs

Section 1 Dian Hong Pharmaceutical Group Co., Ltd

First, the company profile